Global Injection Pen Market Dominated by Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France)
Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption among patients. The global injection penis expected to reach $41.38 Billion by 2022 from $30.97 Billion in 2017, at a CAGR of 6.0%. Segments The …
